Labor Department extends comment period for OSHA vaccinate-or-test mandate
By
Kathleen Steele Gaivin
Dec 01, 2021
The Department of Labor’s Occupational Safety and Health Administration has extended until Jan. 19 the comment period for its COVID-19 vaccination and testing emergency temporary standard.
CMS vaccine mandate blocked in 10 states by federal judge
By
Danielle Brown
Nov 30, 2021
The Biden administration’s COVID-19 vaccination mandate for healthcare workers has been at least temporarily halted in 10 states following an order issued by a federal judge Monday afternoon.
Vaccine makers already testing their shots against omicron variant
Nov 29, 2021
So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant.
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
Fewer deaths reported with enrollment in COVID-19 remote monitoring
Nov 18, 2021
The remote monitoring service, COVID Watch, reduced deaths at 30 and 60 days and was associated with presentation to the emergency department sooner.
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.
Pfizer asks FDA for emergency approval of its COVID-19 antiviral pill
Nov 16, 2021
The request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness.
ACR: Lupus patients can have low immune response to COVID-19 vaccines
Nov 15, 2021
Overall disease activity does not appear to change after vaccination, however.
Pfizer set to ask FDA to approve booster for those 18 and older
Nov 09, 2021
Peter Chin-Hong, M.D., an infectious-disease physician at the University of California, San Francisco, said there is “some value” in young people getting a booster to protect older relatives...
Adults with IBD show antibody response to mRNA COVID-19 vaccine
Nov 09, 2021
After mRNA COVID-19 vaccination, 99% of patients with inflammatory bowel disease had detectable antibodies regardless of immunocompromising therapies.